EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive‐stage small cell lung cancer

Jinmin Han, Wencai Zheng, Jie Jiang, Huan Shi, Chengxin Liu iD

Precision Radiation Oncology · 2026-03 · 10 (1) · 39-47

DOI: 10.1002/pro6.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Radiation Oncology, online erschienen am 11.03.2026. Verfasst von Jinmin Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai Shandong China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We evaluated the effect of thoracic radiotherapy (TRT) on extensive‐stage small‐cell lung cancer (ES‐SCLC) in elderly patients (aged ≥ 60 years) in the era of immunotherapy (IO) and analyzed the prognostic factors to guide personalized treatment.

Methods

The clinical data of 178 elderly patients were reviewed. Kaplan‐Meier curves were generated to estimate the survival rates. Multivariate prognostic analyses were performed using Cox proportional hazards models.

Results

The mOS in the CRT‐IO group was superior to that in the CT‐IO group (22.0 vs. 14.7 months, p = 0.014). In addition, the mPFS in the CRT‐IO group was significantly longer than that in the CT‐IO group (11.2 vs. 7.0 months, p = 0.023). The mOS in the CRT‐IO group was better than that in the CRT group; however, the difference was not statistically significant (22.0 vs. 17.3 months, p = 0.103). Overall survival was the longest in the CRT‐IO group, followed by the CRT and CT‐IO groups.Patients in the low‐dose group had longer survival times than those in the high‐dose group; however, this difference was not statistically significant (all p > 0.05).Multivariate analysis suggested that a KPS (Karnofsky performance status) score ≥ 80 ( p = 0.003) was a good predictor of longer OS, whereas liver metastasis ( p = 0.004) was associated with shorter OS.

Conclusions

CRT‐IO should be prioritized as a treatment for elderly patients with ES‐SCLC with good performance status and liver metastasis. However, CRT could be a viable option for patients with a compromised performance status or for whom economic factors are a concern.

Schlagwörter

Stichwörter der Autor:innen

chemoimmunotherapychemoradiotherapyextensive small cell lung cancerthoracic radiotherapy

Autor:innen und Institutionen

  • Department of Radiotherapy Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai Shandong China.
  • Department of Pharmacy Lijin County Central Hospital Dongying Shandong China.
  • Department of Medical Affairs Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai Shandong China.
  • Department of Gastroenterology Ward Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China.
  • Department of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China.
  • Present/permanent address: Department of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China.

ORCID-Profile: Chengxin Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Han, J., Zheng, W., Jiang, J., Shi, H., & Liu, C. (2026). Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive‐stage small cell lung cancer. Precision Radiation Oncology, 10(1), 39-47. https://doi.org/10.1002/pro6.70051

Vancouver

Han J, Zheng W, Jiang J, Shi H, Liu C. Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive‐stage small cell lung cancer. Precision Radiation Oncology. 2026;10(1):39-47. doi:10.1002/pro6.70051

BibTeX
@article{Han2026,
  author = {Han, Jinmin and Zheng, Wencai and Jiang, Jie and Shi, Huan and Liu, Chengxin},
  title = {Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive‐stage small cell lung cancer},
  journal = {Precision Radiation Oncology},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {39--47},
  doi = {10.1002/pro6.70051}
}
Kostenlos starten →